Mode
Text Size
Log in / Sign up

Multidisciplinary management in T2DM patients yielded a 29.24% remission rate in a single-arm observational studyNearly 1 in 3 Reversed Type 2 Diabetes in Special Clinic

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that multidisciplinary management may be associated with T2DM remission, but causality cannot be established in this observational study.

This real-world study enrolled 171 patients with Type 2 Diabetes Mellitus who received multidisciplinary management at the Diabetes Reversal Clinic. The primary outcome was the remission rate of T2DM, assessed during a follow-up period of more than 24 weeks. Secondary outcomes included changes in fasting blood glucose, 2-hour postprandial blood glucose, HbA1c, blood lipids, and body composition. No adverse events, serious adverse events, discontinuations, or specific tolerability data were reported in the study.

Analysis identified several independent predictors of T2DM remission. Older age was associated with remission (OR = 0.93; 95% CI: 0.89-0.97, P = 0.002). The type of medications at baseline was also an independent predictor (OR = 0.45; 95% CI: 0.26-0.77, P = 0.004). Higher baseline fasting blood glucose levels correlated with lower remission likelihood (OR = 0.64; 95% CI: 0.46-0.89, P = 0.008). Conversely, greater weight loss magnitude was positively associated with remission (OR = 1.15; 95% CI: 1.01-1.31, P = 0.038).

Key limitations include the single-arm observational design, which precludes the establishment of causality. The study phase was not reported, and funding or conflicts of interest were not disclosed. Due to the lack of a control group, the specific contribution of the multidisciplinary management to the observed remission rate remains uncertain. Clinicians should interpret these results with caution and await data from prospective controlled trials before altering standard practice based solely on these findings.

Why this fight feels so hard

Type 2 diabetes is one of the most common long-term illnesses in the world. It happens when the body stops using insulin well, which causes blood sugar to rise.

Over time, high blood sugar can damage the heart, kidneys, eyes, and nerves. Most people are told they will live with it forever and take pills or insulin every day.

That message is heavy. It can make people feel stuck, even when they are doing their best.

The old story is starting to change

For years, doctors treated type 2 diabetes like a one-way road. The goal was to slow it down, not reverse it.

But here's the twist. Newer research shows that some people can actually push the disease into remission. Remission means blood sugar stays in a healthy range without diabetes medicine.

This study tested that idea in a real clinic, with real patients, not just in a lab.

Think of type 2 diabetes like a clogged engine. Insulin is the key that helps sugar move from the blood into the cells for energy. In diabetes, the lock gets sticky and the key no longer turns easily.

A reversal clinic tries to clean the engine instead of just adding more fuel. Doctors, dietitians, nurses, and exercise coaches work together as one team.

They focus on weight loss, better food choices, movement, sleep, stress, and careful use of medicine. The goal is to give the pancreas and the body's cells a chance to reset.

What the study looked at

Researchers followed 171 adults with type 2 diabetes who joined the Diabetes Reversal Clinic for at least 24 weeks. This was a real-world, single-arm study, which means everyone got the treatment and there was no separate comparison group.

The team tracked fasting blood sugar, after-meal blood sugar, long-term sugar control (HbA1c), cholesterol, and body composition. They also looked for clues about who was most likely to succeed.

The numbers that matter

Fifty of the 171 patients reached remission. That is 29.24%, or close to 1 in 3.

People who reached remission tended to be younger. They had lived with diabetes for less time, took fewer medicines at the start, and had better pancreas function to begin with.

They also had lower starting blood sugar, lower triglycerides (a type of blood fat), and lost more weight during the program. In simple terms, the earlier someone acted and the more weight they lost, the better the odds.

This doesn't mean diabetes is cured for life.

Remission is not the same as a cure. Blood sugar can rise again if old habits return or if the disease progresses.

Where this fits in the bigger picture

This study adds to a growing wave of research suggesting that type 2 diabetes is more flexible than doctors once believed. Earlier trials in the UK and other countries have also shown that strong lifestyle changes and weight loss can pause the disease.

What is different here is the team-based, real-world setting. It shows that remission is not just possible in strict research trials. It may also be possible in a regular clinic when patients get enough support.

If you or a loved one has type 2 diabetes, this is a reason for hope, not a do-it-yourself plan. The patients in this study had close medical supervision.

Stopping or changing diabetes medicine on your own can be dangerous. Talk to your doctor about whether a structured weight loss plan, a registered dietitian, or a diabetes education program could be right for you.

Acting earlier in the disease, before many years pass, appears to help the most.

Honest limits of the study

This was a single-arm observational study from one clinic. There was no control group to compare against, so the results cannot prove cause and effect.

The follow-up was also fairly short at 24 weeks. We do not yet know how many of these patients will stay in remission one, five, or ten years later.

The researchers say larger, controlled trials are needed to confirm these findings and see how long remission can last. Future studies will likely test which parts of the team-based approach matter most, such as diet type, exercise, or specific medicines.

For now, the message is careful but encouraging. Type 2 diabetes may not always be a life sentence, especially for people who get strong, early, team-based care.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
ObjectiveTo evaluate the effects of multidisciplinary management in the Diabetes Reversal Clinic on the remission of type 2 diabetes mellitus (T2DM), and explore the predictive factors for remission of diabetes.MethodsThis was a real-world, single-arm observational study. Patients with T2DM who received remission-oriented treatment at the Diabetes Reversal Clinic and followed up regularly for more than 24 weeks were included. The primary outcome was the remission rate of T2DM, and the secondary outcomes were changes in fasting blood glucose (FBG), 2-hour postprandial blood glucose, HbA1c, blood lipids, and body composition. Differences in clinical characteristics between the remission and non-remission groups were analyzed. The multivariate logistic regression analysis was performed to screen predictive factors.ResultsThe remission rate was 29.24% (50/171) after multidisciplinary management in the Diabetes Reversal Clinic. The remission group was younger, had a shorter duration of diabetes, used fewer types of medications at baseline, had a lower FBG and HbA1c, a higher β-cell function index HOMA-β, and a lower triglyceride level. The multivariate logistic regression analysis revealed that age (OR = 0.93, 95% CI: 0.89-0.97, P = 0.002), type of medications at baseline (OR = 0.45, 95% CI: 0.26-0.77, P = 0.004), baseline FBG (OR = 0.64, 95% CI: 0.46-0.89, P = 0.008), and weight loss magnitude (OR = 1.15, 95% CI: 1.01-1.31, P = 0.038) were independent predictors of T2DM remission.ConclusionIn this real-world study, the remission rate of T2DM patients who visited the Diabetes Reversal Clinic for more than 24 weeks was 29.24% (50/171). Younger age, shorter disease duration, fewer baseline medications, lower FBG and HbA1c, higher HOMA-β, lower triglycerides, and greater weight loss were associated with remission of T2DM. Among them, age, baseline medication type, baseline FBG, and weight loss were identified as factors independently associated with remission. However, due to the single-arm observational design, causality cannot be established, and further prospective controlled trials are required to confirm these findings.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.